← Back to Search
Enhanced Oral Bioavailability Of The Antiretroviral Efavirenz Encapsulated In Poly(epsilon-caprolactone) Nanoparticles By A Spray-drying Method.
Lesego L. Tshweu, L. Katata, L. Kalombo, D. Chiappetta, C. Hõcht, A. Sosnik, H. Swai
Published 2014 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
AIM To encapsulate efavirenz (EFV) within poly(epsilon-caprolactone) (PCL) nanoparticles (NPs) and compare the oral pharmacokinetics with that of EFV-loaded micelles and pure EFV NPs. MATERIALS & METHODS EFV-loaded PCL NPs were produced by a double-emulsion/spray-drying method. RESULTS NPs displayed a hydrodynamic diameter of 200-250 nm. The encapsulation efficiency was 86-93% and the mass recovery was above 60%. X-ray diffraction indicated that drug and PCL underwent amorphization during the spray-drying process. Encapsulation within NPs significantly increased the maximum concentration in plasma and the bioavailability. CONCLUSION EFV-loaded PCL NPs represent a promising platform to develop scalable pharmaceuticals with improved (bio)pharmaceutic performance. Original submitted 2 May 2013; Revised submitted 4 September 2013.
This paper references
Effect of novel stabilizers--cationic polymers on the particle size and physical stability of poorly soluble drug nanocrystals.
W. Sun (2012)
Poly(ethylene glycol)-poly(epsilon-caprolactone) block oligomers as injectable materials
A. Sosnik (2003)
Design and formulation of nano-sized spray dried efavirenz-part I: influence of formulation parameters
L. Katata (2012)
Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.
B. Mishra (2010)
Treatment for adult HIV infection.
P. Yeni (2004)
Kinetics and Mechanism of Hydrolysis of Efavirenz
M. Maurin (2004)
Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs
Wagh Vinod Tukaram (2013)
Synthesis of Cyclodextrin and Sugar‐Based Oligomers for the Efavirenz Drug Delivery
Indrajit Shown (2010)
Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
J. das Neves (2010)
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan
Chin-San Wu (2005)
Microencapsulation techniques, factors influencing encapsulation efficiency
N. N. Jyothi (2010)
Irregular variations in the melting point of size-selected atomic clusters
M. Schmidt (1998)
In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.
B. Semete (2010)
Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles.
D. Chiappetta (2011)
The effect of particle size distribution on dissolution rate and oral absorption
R. J. Hintz (1989)
Quality by design approach to understand the process of nanosuspension preparation.
S. Verma (2009)
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
S. Hammer (2006)
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase.
S. Alcaro (2011)
Production methods for nanodrug particles using the bottom-up approach.
H. Chan (2011)
Nanosizing--oral formulation development and biopharmaceutical evaluation.
F. Kesisoglou (2007)
Guidelines for the use of antiretroviral agents in pediatric HIV infection
J. Oleske (1998)
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization.
I. Shin (1998)
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
S. Wong (2006)
Hydrolysis of polyesters by lipases
Y. Tokiwa (1977)
Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.
D. Chiappetta (2007)
Fast and efficient synthesis of high molecular weight poly(epsilon-caprolactone) diols by microwave-assisted polymer synthesis
Gustavo Gotelli (2011)
Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients.
J. Williams (2013)
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys.
S. Balani (1999)
Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine
J. das Neves (2011)
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
H. L. Wong (2010)
Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections.
K. Sachs-Barrable (2008)
Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review.
Tapan K. Dash (2012)
Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system
B. Sarmento (2011)
Chitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery
Fernanda Andrade (2011)
The return of a forgotten polymer : Polycaprolactone in the 21st century
M. Woodruff (2009)
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
E. Clercq (2009)
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
M. Dybul (2002)
British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2006)
B. Gazzard (2005)
N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz.
D. Chiappetta (2010)
Chemical interactions study of antiretroviral drugs efavirenz and lamivudine concerning the development of stable fixed-dose combination formulations for AIDS treatment
Elionai Cassiana Lima Gomes (2013)
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
Antiretroviral Therapy for HIV Infection
G. Moyle (2012)
Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.
A. Sosnik (2009)
Nanotechnology solutions for infectious diseases in developing nations. Preface.
A. Sosnik (2010)
PEO-PPO-PEO-based poly(ether ester urethane)s as degradable reverse thermo-responsive multiblock copolymers.
D. Cohn (2006)
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
Electronic and resonance effects on the lonization of structural analogues of efavirenz
S. Rabel (2008)
Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
S. Das (2011)
Overview of Pharmacokinetics
L. Aimone (2005)
British HIV Association (BHIVA) Guideline Development Manual British HIV Association
I Williams (2011)
Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].
D. Chiappetta (2010)
Synergistic encapsulation of the anti - HIV agent efavirenz within poly ( ethylene oxide ) – poly ( propylene oxide ) mixed polymeric micelles
Application of nanotechnologies for improved immune response against infectious diseases in the developing world.
M. Look (2010)
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
U. Gupta (2010)
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
Bg Gazzard and (2001)
Efavirenz plasma concentrations at 1, 3, and 6 months post-antiretroviral therapy initiation in HIV type 1-infected South African children.
M. Viljoen (2010)
Antiretroviral Therapy for HIV Infection
B. Rewari (2007)
Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
Katia P. Seremeta (2013)
METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS
S. Kim (1998)
Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.
D. Chiappetta (2013)
Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision.
B. Stilwell (2006)
Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles.
D. Chiappetta (2011)
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.
C. Carpenter (1998)
Development of Novel Biodegradable Polymeric Nanoparticles-in-Microsphere Formulation for Local Plasmid DNA Delivery in the Gastrointestinal Tract
M. Bhavsar (2007)
This paper is referenced by
Nanoformulated Delivery Systems of Essential Nutraceuticals and Their Applications
Lebogang Maureen Katata-Seru (2019)
Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies.
O. Sued (2016)
Amphiphilic block copolymers-based mixed micelles for noninvasive drug delivery
H. Xu (2016)
Aliphatic Polyester Protein Drug Delivery Systems
M. N. V. Ravi Kumar (2017)
Lipid based delivery of Efavirenz: An answer to its erratic absorption and food effect
S. Kamboj (2018)
Spray drying as an advantageous strategy for enhancing pharmaceuticals bioavailability
A. Salama (2019)
Preparation of Efavirenz resinate by spray drying using response surface methodology and its physicochemical characterization for taste masking
U. Verma (2020)
Advances in nanomedicine drug delivery applications for HIV therapy
P. Curley (2018)
Functionalization of Cotton Fabrics with Polycaprolactone Nanoparticles for Transdermal Release of Melatonin
Daniele Massella (2017)
Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability.
Katia P. Seremeta (2014)
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
C. Hoffmeister (2017)
Optimisation of the microencapsulation of lavender oil by spray drying
Ayah M Burhan (2019)
Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers.
A. Sosnik (2015)
Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
A. Kermanizadeh (2018)
Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them.
A. Sosnik (2016)
An oral formulation of efavirenz‐loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile
P. Kumar (2017)
Injectable long‐acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles
Sai Archana Krovi (2018)
Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections
D. Lembo (2018)
Nanodrugs in Medicine and Healthcare: Oral Delivery
A. Sosnik (2016)
Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation*
Rana Zainuddin (2017)
Recent Advances in Drug Delivery Strategies for Improved Therapeutic Efficacy of Efavirenz.
Mitali H Patel (2019)
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Y. Zu (2014)
Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation
Ravindra N Kamble (2015)
Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
M. Shahab (2020)
Production of dasatinib encapsulated spray-dried poly (lactic-co-glycolic acid) particles
Rajat Chauhan (2019)
Electrohydrodynamic atomization and spray‐drying for the production of pure drug nanocrystals and co‐crystals☆
Roni Sverdlov Arzi (2018)
Drug self-assembly: A phenomenon at the nanometer scale with major impact in the structure–biological properties relationship and the treatment of disease
A. Sosnik (2016)